List of Tables
Table 1. Global Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Assays & kits
Table 3. Key Players of Instruments & Analyzers
Table 4. Key Players of Software & Services
Table 5. Global Point-of-care Molecular Diagnostic Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Point-of-care Molecular Diagnostic Solution Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2020-2025)
Table 9. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Point-of-care Molecular Diagnostic Solution Market Share by Region (2026-2031)
Table 11. Point-of-care Molecular Diagnostic Solution Market Trends
Table 12. Point-of-care Molecular Diagnostic Solution Market Drivers
Table 13. Point-of-care Molecular Diagnostic Solution Market Challenges
Table 14. Point-of-care Molecular Diagnostic Solution Market Restraints
Table 15. Global Point-of-care Molecular Diagnostic Solution Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Point-of-care Molecular Diagnostic Solution Market Share by Players (2020-2025)
Table 17. Global Top Point-of-care Molecular Diagnostic Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2024)
Table 18. Ranking of Global Top Point-of-care Molecular Diagnostic Solution Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Point-of-care Molecular Diagnostic Solution, Headquarters and Area Served
Table 21. Global Key Players of Point-of-care Molecular Diagnostic Solution, Product and Application
Table 22. Global Key Players of Point-of-care Molecular Diagnostic Solution, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Point-of-care Molecular Diagnostic Solution Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2020-2025)
Table 26. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Type (2026-2031)
Table 28. Global Point-of-care Molecular Diagnostic Solution Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Application (2020-2025)
Table 30. Global Point-of-care Molecular Diagnostic Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Application (2026-2031)
Table 32. North America Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Point-of-care Molecular Diagnostic Solution Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Point-of-care Molecular Diagnostic Solution Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Point-of-care Molecular Diagnostic Solution Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Laboratories Company Details
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product
Table 50. Abbott Laboratories Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. F. Hoffmann-La Roche AG Company Details
Table 53. F. Hoffmann-La Roche AG Business Overview
Table 54. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product
Table 55. F. Hoffmann-La Roche AG Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 56. F. Hoffmann-La Roche AG Recent Development
Table 57. Becton, Dickinson and Company Company Details
Table 58. Becton, Dickinson and Company Business Overview
Table 59. Becton, Dickinson and Company Point-of-care Molecular Diagnostic Solution Product
Table 60. Becton, Dickinson and Company Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 61. Becton, Dickinson and Company Recent Development
Table 62. BioMerieux Company Details
Table 63. BioMerieux Business Overview
Table 64. BioMerieux Point-of-care Molecular Diagnostic Solution Product
Table 65. BioMerieux Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 66. BioMerieux Recent Development
Table 67. Bio-Rad Laboratories, Inc. Company Details
Table 68. Bio-Rad Laboratories, Inc. Business Overview
Table 69. Bio-Rad Laboratories, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 70. Bio-Rad Laboratories, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 71. Bio-Rad Laboratories, Inc. Recent Development
Table 72. Cepheid, Inc. Company Details
Table 73. Cepheid, Inc. Business Overview
Table 74. Cepheid, Inc. Point-of-care Molecular Diagnostic Solution Product
Table 75. Cepheid, Inc. Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 76. Cepheid, Inc. Recent Development
Table 77. Danaher Corporation Company Details
Table 78. Danaher Corporation Business Overview
Table 79. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product
Table 80. Danaher Corporation Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 81. Danaher Corporation Recent Development
Table 82. Johnson and Johnson Company Details
Table 83. Johnson and Johnson Business Overview
Table 84. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product
Table 85. Johnson and Johnson Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 86. Johnson and Johnson Recent Development
Table 87. Bayer Healthcare Company Details
Table 88. Bayer Healthcare Business Overview
Table 89. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product
Table 90. Bayer Healthcare Revenue in Point-of-care Molecular Diagnostic Solution Business (2020-2025) & (US$ Million)
Table 91. Bayer Healthcare Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Point-of-care Molecular Diagnostic Solution Picture
Figure 2. Global Point-of-care Molecular Diagnostic Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Molecular Diagnostic Solution Market Share by Type: 2024 VS 2031
Figure 4. Assays & kits Features
Figure 5. Instruments & Analyzers Features
Figure 6. Software & Services Features
Figure 7. Global Point-of-care Molecular Diagnostic Solution Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Point-of-care Molecular Diagnostic Solution Market Share by Application: 2024 VS 2031
Figure 9. Physicians’ Offices Case Studies
Figure 10. Hospitals & ICUs Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Other End Users Case Studies
Figure 13. Point-of-care Molecular Diagnostic Solution Report Years Considered
Figure 14. Global Point-of-care Molecular Diagnostic Solution Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Point-of-care Molecular Diagnostic Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Point-of-care Molecular Diagnostic Solution Market Share by Region: 2024 VS 2031
Figure 17. Global Point-of-care Molecular Diagnostic Solution Market Share by Players in 2024
Figure 18. Global Top Point-of-care Molecular Diagnostic Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Point-of-care Molecular Diagnostic Solution Revenue in 2024
Figure 20. North America Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Point-of-care Molecular Diagnostic Solution Market Share by Country (2020-2031)
Figure 22. United States Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Point-of-care Molecular Diagnostic Solution Market Share by Country (2020-2031)
Figure 26. Germany Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Point-of-care Molecular Diagnostic Solution Market Share by Region (2020-2031)
Figure 34. China Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Point-of-care Molecular Diagnostic Solution Market Share by Country (2020-2031)
Figure 42. Mexico Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Point-of-care Molecular Diagnostic Solution Market Share by Country (2020-2031)
Figure 46. Turkey Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Point-of-care Molecular Diagnostic Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 50. F. Hoffmann-La Roche AG Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 51. Becton, Dickinson and Company Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 52. BioMerieux Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 53. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 54. Cepheid, Inc. Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 55. Danaher Corporation Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 56. Johnson and Johnson Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 57. Bayer Healthcare Revenue Growth Rate in Point-of-care Molecular Diagnostic Solution Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
